Delivery Order SPE2DB20D7059-SPE2DB24FQDH8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The award, valued at $1,058.60, has a period of performance through March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a specialty pharmaceutical product, WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The delivery order, valued at $1,097.08, has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This is a $8,137.32 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of December 31, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D2007|SPE2DB24FJ1MD) worth $1,257.04 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a ceiling value of $14,827.52 and a performance period through April 15, 2024. Amerisourcebergen Drug Corporation is the prime contractor and does not have any major subcontractors listed. This delivery order is placed...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,632.08, is for the delivery of 1 mg/0.5 ml pens of the medication WEGOVY. The order has a firm fixed price and an ultimate completion date of November 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,979.10 and a performance period ending on October 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various defense...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,339.62 order is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The delivery order has a completion date of March 11, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract (IDC) valued at up...
- The Defense Logistics Agency awarded a $1,632.97 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a $1,645.62 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML and has a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense through...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQDH8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order, worth $1,097.08, is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. This order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/10/24 |